Because most women with HR-positive breast cancer are advised to avoid hormone therapy, a nonhormonal option matters. The FDA ...
Supported by phase 3 OASIS-4 data, elinzanetant significantly reduced daily hot flash frequency in women receiving endocrine therapy for HR-positive breast cancer.
Share on Pinterest A progesterone-mimicking drug may help slow breast cancer tumor growth, according to research. Image Credit: Fiordaliso/Getty Images A recent study found that a synthetic ...
Share on Pinterest Scientists have found that a treatment for hot flashes in menopause also has breast cancer-reducing activity. The Good Brigade/Getty Images Breast cancer is the most common cancer ...
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen treatment for women with breast cancer, a new Cambridge-led trial has found. A low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results